Hepatitis-C-Virus-Antikörper (HCV) bei Patienten unter chronischer Hämodialyse.

P. Kühnl; M. Roggendorf; W. Sibrowski; F. Deinhardt; R. Laufs; K. Bornhövd; G. Kalmar; S. Seidl; B. O. Böhm

Hepatitis-C-Virus-Antikörper (HCV) bei Patienten unter chronischer Hämodialyse.

P. Kühnl
, M. Roggendorf
, W. Sibrowski
, F. Deinhardt
, R. Laufs
, K. Bornhövd
, G. Kalmar
, S. Seidl
, B. O. Böhm

Universität Hamburg

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

3 Zitate (Scopus)

Abstract

Patients undergoing chronic hemodialysis are frequently affected by nosocomial viral infections, as indicated by the high prevalence of HBV antibodies. The question, to what extent HCV is transmitted by blood transfusions (NANB-PTH), or acquired in a nosocomial manner, is still unanswered. We therefore evaluated the HCV antibody rate of 387 sera of dialysis patients on the "Eurotransplant" waiting list. The HCV antibody reactivity ranged from 5.4 to 12.0% between different dialysis centers. In highly immunized (HLA antibody positive) long-term dialysis patients 31.3% (vs. 8.3% in non-immunized patients) were HCV antibody positive.

Titel in Übersetzung	Hepatitis C virus antibodies (HCV) in patients treated with chronic hemodialysis
Originalsprache	Deutsch
Seiten (von - bis)	27-29
Seitenumfang	3
Fachzeitschrift	Beitrage zur Infusionstherapie = Contributions to infusion therapy
Jahrgang	26
Publikationsstatus	Veröffentlicht - 1990
Extern publiziert	Ja

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

@article{b001dd39bc5f4655bce4b10cd3608c1e,

title = "Hepatitis-C-Virus-Antik{\"o}rper (HCV) bei Patienten unter chronischer H{\"a}modialyse.",

abstract = "Patients undergoing chronic hemodialysis are frequently affected by nosocomial viral infections, as indicated by the high prevalence of HBV antibodies. The question, to what extent HCV is transmitted by blood transfusions (NANB-PTH), or acquired in a nosocomial manner, is still unanswered. We therefore evaluated the HCV antibody rate of 387 sera of dialysis patients on the {"}Eurotransplant{"} waiting list. The HCV antibody reactivity ranged from 5.4 to 12.0\% between different dialysis centers. In highly immunized (HLA antibody positive) long-term dialysis patients 31.3\% (vs. 8.3\% in non-immunized patients) were HCV antibody positive.",

author = "P. K{\"u}hnl and M. Roggendorf and W. Sibrowski and F. Deinhardt and R. Laufs and K. Bornh{\"o}vd and G. Kalmar and S. Seidl and B{\"o}hm, \{B. O.\}",

year = "1990",

language = "Deutsch",

volume = "26",

pages = "27--29",

journal = "Beitrage zur Infusionstherapie = Contributions to infusion therapy",

issn = "1011-6974",

publisher = "S. Karger AG",

}

TY - JOUR

T1 - Hepatitis-C-Virus-Antikörper (HCV) bei Patienten unter chronischer Hämodialyse.

AU - Kühnl, P.

AU - Roggendorf, M.

AU - Sibrowski, W.

AU - Deinhardt, F.

AU - Laufs, R.

AU - Bornhövd, K.

AU - Kalmar, G.

AU - Seidl, S.

AU - Böhm, B. O.

PY - 1990

Y1 - 1990

N2 - Patients undergoing chronic hemodialysis are frequently affected by nosocomial viral infections, as indicated by the high prevalence of HBV antibodies. The question, to what extent HCV is transmitted by blood transfusions (NANB-PTH), or acquired in a nosocomial manner, is still unanswered. We therefore evaluated the HCV antibody rate of 387 sera of dialysis patients on the "Eurotransplant" waiting list. The HCV antibody reactivity ranged from 5.4 to 12.0% between different dialysis centers. In highly immunized (HLA antibody positive) long-term dialysis patients 31.3% (vs. 8.3% in non-immunized patients) were HCV antibody positive.

AB - Patients undergoing chronic hemodialysis are frequently affected by nosocomial viral infections, as indicated by the high prevalence of HBV antibodies. The question, to what extent HCV is transmitted by blood transfusions (NANB-PTH), or acquired in a nosocomial manner, is still unanswered. We therefore evaluated the HCV antibody rate of 387 sera of dialysis patients on the "Eurotransplant" waiting list. The HCV antibody reactivity ranged from 5.4 to 12.0% between different dialysis centers. In highly immunized (HLA antibody positive) long-term dialysis patients 31.3% (vs. 8.3% in non-immunized patients) were HCV antibody positive.

UR - https://www.scopus.com/pages/publications/17644443166

M3 - Artikel

C2 - 1703848

AN - SCOPUS:17644443166

SN - 1011-6974

VL - 26

SP - 27

EP - 29

JO - Beitrage zur Infusionstherapie = Contributions to infusion therapy

JF - Beitrage zur Infusionstherapie = Contributions to infusion therapy

ER -

Hepatitis-C-Virus-Antikörper (HCV) bei Patienten unter chronischer Hämodialyse.

Abstract

UN SDGs

Andere Dateien und Links

Fingerprint

Dieses zitieren